Marshall Financial Group (Maryland)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Buy
10,563
+966
+10% +$200K 0.3% 65
2026
Q1
$2.15M Buy
9,597
+375
+4% +$93.5K 0.34% 58
2025
Q4
$2.22M Sell
9,222
-545
-6% -$139K 0.43% 48
2025
Q3
$2.67M Buy
9,767
+243
+3% +$66.4K 0.52% 42
2025
Q2
$2.44M Sell
9,524
-952
-9% -$227K 0.48% 40
2025
Q1
$2.35M Sell
10,476
-51
-0.5% -$11.9K 0.51% 38
2024
Q4
$2.41M Sell
10,527
-296
-3% -$71.3K 0.58% 39
2024
Q3
$2.64M Sell
10,823
-82
-0.8% -$18.3K 0.63% 34
2024
Q2
$2.09M Buy
10,905
+433
+4% +$87.9K 0.58% 43
2024
Q1
$2.07M Buy
10,472
+441
+4% +$80.8K 0.6% 43
2023
Q4
$1.73M Buy
+10,031
New +$1.54M 0.56% 51
2022
Q4
Sell
-4,238
Closed -$925K 193
2022
Q3
$925K Buy
4,238
+14
+0.3% +$3.19K 0.39% 73
2022
Q2
$886K Buy
4,224
+2,852
+208% +$607K 0.35% 86
2022
Q1
$333K Sell
1,372
-73
-5% -$17.7K 0.14% 160
2021
Q4
$376K Sell
1,445
-3,714
-72% -$964K 0.14% 161
2021
Q3
$1.36M Buy
5,159
+115
+2% +$31.4K 0.7% 30
2021
Q2
$1.24M Sell
5,044
-1,123
-18% -$236K 0.67% 32
2021
Q1
$1.2M Buy
6,167
+188
+3% +$37.7K 0.72% 50
2020
Q4
$1.27M Buy
+5,979
New +$1.19M 0.83% 34

Other funds holding RMD

Marshall Financial Group (Maryland)'s RMD Position: Q2 2026 in Review

Marshall Financial Group (Maryland) increased its ResMed (RMD) stake by 10% in Q2 2026, buying an estimated $200K and bringing the position to 10,563 shares worth $2.06M. The position accounts for 0.3% of the portfolio, ranked #65.

Marshall Financial Group (Maryland) first reported a position in RMD in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.67M in Q3 2025. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Marshall Financial Group (Maryland) held 10,563 shares of ResMed worth $2.06M as of Q2 2026.
  • Marshall Financial Group (Maryland) bought 966 ResMed shares in Q2 2026, an estimated $200K.
  • ResMed made up 0.3% of Marshall Financial Group (Maryland)'s portfolio in Q2 2026, its #65 holding.
  • Marshall Financial Group (Maryland) first reported a position in ResMed in Q4 2020 and has held it in 19 quarters since.
  • Marshall Financial Group (Maryland)'s ResMed position peaked at $2.67M in Q3 2025.
  • 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q2 2026, filed 20 Jul 2026.